发明申请
US20070135461A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
有权
杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]
- 专利标题: Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
- 专利标题(中): 杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]
-
申请号: US11637545申请日: 2006-12-12
-
公开(公告)号: US20070135461A1公开(公告)日: 2007-06-14
- 发明人: James Rodgers , Stacey Shepard , Thomas Maduskuie , Haisheng Wang , Nikoo Falahatpisheh , Maria Rafalski , Argyrios Arvanitis , Louis Storace , Ravi Jalluri , Jordan Fridman , Krishna Vaddi
- 申请人: James Rodgers , Stacey Shepard , Thomas Maduskuie , Haisheng Wang , Nikoo Falahatpisheh , Maria Rafalski , Argyrios Arvanitis , Louis Storace , Ravi Jalluri , Jordan Fridman , Krishna Vaddi
- 主分类号: A61K31/519
- IPC分类号: A61K31/519 ; A61K31/4745 ; C07D487/02 ; C07D471/02
摘要:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.